Pharming Group Engages at Global Investment Conference Soon

Author: Ryan Hughes Updated: 09-03-2025 02:17 AM

Pharming Group's Upcoming Presentation at an Investment Conference

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is poised to make a significant impact at the H.C. Wainwright 27th Annual Global Investment Conference. This notable event will take place in New York, where Pharming's management team is excited to share their insights and advancements.

Key Participation Details

Fabrice Chouraqui, the company's Chief Executive Officer, is scheduled to present on a prominent stage at the conference on September 8. The presentation will commence at 1:30 PM EDT, allowing attendees a chance to learn more about Pharming's innovative pursuits.

Transforming Lives through Innovation

Pharming Group N.V. specializes in biopharmaceutical development aimed at addressing rare and life-threatening diseases. With a strong commitment to improving patients' lives, they are developing an array of new treatments encompassing both small molecules and biologics. Through this dedication, Pharming is not just a company; it represents hope for many.

Expanding Global Reach

Headquartered in Leiden, the Netherlands, Pharming has a robust presence around the world, providing access to their medicines across over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. This international approach underscores their mission: to ensure that those with rare diseases have access to the treatments they need.

Contacting and Engaging with Pharming

For those interested in deeper insights or wishing to set up a one-on-one meeting with Pharming's management, Investor Relations welcomes outreach via email at investor@pharming.com. This engagement reflects Pharming's open-door policy concerning investor communication.

Stay Informed

To stay updated on Pharming’s developments and upcoming events, visit their official website. For those who prefer social media, Pharming is also actively present on LinkedIn, fostering connections and sharing updates with a broader community.

Conclusion

Pharming Group N.V. continues to lead the way in biopharmaceutical innovation, with a keen focus on transforming lives through their groundbreaking work. As they prepare for their presentation at the H.C. Wainwright Global Investment Conference, there is much anticipation for the insights that will emerge from their engagement.

Frequently Asked Questions

What is the focus of Pharming Group N.V.?

Pharming Group N.V. is dedicated to developing and commercializing therapies for rare and life-threatening diseases.

When will Pharming's CEO present at the conference?

Fabrice Chouraqui will present on September 8 at 1:30 PM EDT.

How can investors engage with Pharming?

Investors can reach out to Pharming's Investor Relations team via email at investor@pharming.com to schedule meetings.

Where is Pharming Group N.V. headquartered?

Pharming is headquartered in Leiden, the Netherlands, with a global presence.

On which platforms can I find more information about Pharming?

To learn more about Pharming, visit their official website or follow them on LinkedIn.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.